These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 841390)

  • 1. Close monitoring is essential during isoniazid prophylaxis.
    Atuk NO; Hart AD; Hunt EH
    South Med J; 1977 Feb; 70(2):156-9. PubMed ID: 841390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid-associated hepatitis--serum enzyme determinations and histologic features.
    Lewis JE; Mello P; Knauer CM
    West J Med; 1975 May; 122(5):371-6. PubMed ID: 1130028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients.
    Byrd RB; Horn BR; Solomon DA; Griggs GA
    JAMA; 1979 Mar; 241(12):1239-41. PubMed ID: 762788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid liver injury during chemoprophylaxis in children.
    Spyridis P; Sinaniotis C; Papadea I; Oreopoulos L; Hadjiyiannis S; Papadatos C
    Arch Dis Child; 1979 Jan; 54(1):65-7. PubMed ID: 420524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underutilization of isoniazid chemoprophylaxis in tuberculosis contacts 50 years of age and older. A prospective analysis.
    Sorresso DJ; Mehta JB; Harvill LM; Bentley S
    Chest; 1995 Sep; 108(3):706-11. PubMed ID: 7656620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid hepatitis in adolescents.
    Litt IF; Cohen MI; McNamara H
    J Pediatr; 1976 Jul; 89(1):133-5. PubMed ID: 819639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid hepatotoxicity in renal transplant recipients.
    Antony SJ; Ynares C; Dummer JS
    Clin Transplant; 1997 Feb; 11(1):34-7. PubMed ID: 9067692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy.
    Mitchell JR; Long MW; Thorgeirsson UP; Jollow DJ
    Chest; 1975 Aug; 68(2):181-90. PubMed ID: 1080096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.
    Kopanoff DE; Snider DE; Caras GJ
    Am Rev Respir Dis; 1978 Jun; 117(6):991-1001. PubMed ID: 666111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana.
    Tedla Z; Nyirenda S; Peeler C; Agizew T; Sibanda T; Motsamai O; Vernon A; Wells CD; Samandari T
    Am J Respir Crit Care Med; 2010 Jul; 182(2):278-85. PubMed ID: 20378730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective: preventive isoniazid therapy and the liver.
    Israel HL; Gottlieb JE; Maddrey WC
    Chest; 1992 May; 101(5):1298-301. PubMed ID: 1582287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal hepatic necrosis due to isoniazid chemoprophylaxis in a 15-year-old girl.
    Vanderhoof JA; Ament ME
    J Pediatr; 1976 May; 88(5):867-8. PubMed ID: 1271153
    [No Abstract]   [Full Text] [Related]  

  • 13. Positive tuberculin skin tests and isoniazid chemoprophylaxis.
    Pickwell SM
    Nurse Pract; 1984 Apr; 9(4):28, 30-1. PubMed ID: 6328384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.
    Bailey WC; Taylor SL; Dascomb HE; Greenberg HB; Ziskind MM
    Am Rev Respir Dis; 1973 Apr; 107(4):523-9. PubMed ID: 4697661
    [No Abstract]   [Full Text] [Related]  

  • 16. Isoniazid hepatitis.
    Maddrey WC; Boitnott JK
    Ann Intern Med; 1973 Jul; 79(1):1-12. PubMed ID: 4721174
    [No Abstract]   [Full Text] [Related]  

  • 17. Isoniazid-associated hepatitis. Report of an outbreak.
    Garibaldi RA; Drusin RE; Ferebee SH; Gregg MB
    Am Rev Respir Dis; 1972 Sep; 106(3):357-65. PubMed ID: 5080707
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?
    Gordin FM; Cohn DL; Matts JP; Chaisson RE; O'Brien RJ; ; ;
    Clin Infect Dis; 2004 Aug; 39(4):561-5. PubMed ID: 15356822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection.
    Gray EL; Goldberg HF
    Intern Med J; 2016 Mar; 46(3):281-7. PubMed ID: 26648478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW; Snider DE; Farer LS
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.